Table 3.
Study | Age mean ± SD or median | Female N (%) |
IV-tPA given N (%) |
Occlusion location N (%) |
Type II DM N (%) |
HTN N (%) |
HLD N (%) | A-Fib N (%) |
Smoker N (%) |
NIHSS at presentation mean or mediana | Onset to Needle Time (mins) mean or mediana | Onset to Recanalization Time (min) mean or mediana |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Full Texts | ||||||||||||
Huded et al, 201416 | mean, 49.53 | – | 0 (0.0) | MCA - 16 (53.0) ICA - 10 (33.3) BA - 4 (13.3) |
– | – | – | – | – | mean, 20.4 | – | – |
Mansour et al, 201718 | 62 ± 11.73 | 58 (51.3) | 8 (7.0) | MCA M1 - 33 (29.2) MCA M2 - 12 (10.6) Carotid T - 17 (15) Total Carotid - 27 (23.9) BA - 21 (18.6) PCA - 2 (1.7) ACA - 1 (0.9) |
85 (75.2) | 61 (53.9) | 85 (75.2) | 52 (46.0) | – | 16.7 ± 3.2 | 208.55 ± 53.49 | – |
Luu et al, 202017 | 61.29 ± 14.49 | 35 (47.9) | 21 (28.8) | MCA - 28 (38.4) ICA - 33 (45.2) BA - 10 (13.7) PCA - 2 (2.7) |
– | 24 (32.9) | – | 36 (49.3) | – | 17.1 ± 5.3 | – | 251.68 ± 104.70 |
Phuoc et al, 202021 | 61.4 ± 13.4 | 26 (70.3) | 13 (35.1) | MCA - 19 (51.4) ICA- 13 (35.1) BA - 5 (13.5) |
– | – | – | – | – | 17.3 ± 6.9 | – | – |
Mesiano et al, 202119 (MT group) | median, 55 (38–79) | 8 (57.1) | 0 (0.0) | MCA M1 - 5 (33.3) MCA M2 - 3 (20.0) ICA - 4 (26.7) BA - 3 (20.0) |
5 (33.0) | 8 (53.3) | 4 (26.7) | 5 (33.3) | 8 (53.3) | median, 13 | median, 360 | median, 454 |
Mesiano et al, 202119 (IVT/MT group) | median, 56.50 (37–85) | 2 (13.3) | 14 (100.0) | MCA M1 - 5 (35.7) MCA M2 - 7 (50.0) ICA - 2 (14.3) |
3 (21.4) | 9 (64.3) | 1 (7.1) | 2 (14.3) | 6 (42.9) | median, 13 | median, 358 | median, 414 |
Vibha et al, 202222 | – | – | – | – | – | – | – | – | – | – | – | – |
Ngoc et al, 202120 | 62.14 ± 13.3 | – | – | – | – | – | – | – | – | 16.2 ± 7.85 | – | – |
Abstracts | ||||||||||||
Nagesh et al, 201625 | – | – | – | – | – | – | – | – | – | – | – | – |
Salvadeeswaran et al, 201627 | – | – | – | MCA M1 – 8 (61.5) MCA M2 – 2 (15.4) ICA – 2 (15.4) Posterior – 1 (7.7) |
– | – | – | – | – | – | – | – |
Fadli, 201724 | mean, 66.6 | – | 4 (66.7) | MCA M1 – 3 (50.0) Carotid T – 3 (50.0) |
– | – | – | – | – | – | mean, 348.6 | – |
Pishjoo et al, 201926 | 55.9 ± 13.5 | 50 (44.0) | – | MCA – 57 (50.0) ICA – 49 (43.0) BA – 8 (7.0) |
– | – | – | – | – | 16.5 ± 5.1 | 336 ± 138 | – |
Subir et al, 201928 | – | – | 2 (20.0) | – | – | – | – | – | – | mean, 16 | – | – |
Banga et al, 202023 | – | – | – | – | – | – | – | – | – | – | – | – |
Viet Phuong et al, 202029 | 4 (11.1) | – | – | – | – | – | – | median, 13 | – | – | ||
Tran et al, 202129 | 64.4 ± 11.4 | – | – | – | – | – | – | – | – | median, 15 | – | – |
Abbreviations and Acronyms: min, minutes; IV-tPA, intravenous tissue plasminogen activator; HTN, hypertension; HLD, hyperlipidemia; A-Fib, atrial fibrillation; NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; -, data not available; PCA, posterior cerebral artery; ACA, anterior cerebral artery; ICA, internal carotid artery; BA, basilar artery; MT; mechanical thrombectomy; IVT, intravenous thrombolysis.
Standard deviation and interquartile range included if specified in the publication.